GBIO
Income statement / Annual
Last year (2024), Generation Bio Co.'s total revenue was $19.89 M,
an increase of 236.92% from the previous year.
In 2024, Generation Bio Co.'s net income was -$131.67 M.
See Generation Bio Co.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$19.89 M |
$5.90 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$36.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.43 M
|
$1.86 M
|
$0.00
|
| Gross Profit |
$19.89 M
|
$5.90 M
|
$0.00
|
$0.00
|
-$3.43 M
|
-$1.86 M
|
$36.00 K
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
0
|
1
|
| Research and Development Expenses |
$61.31 M
|
$93.62 M
|
$96.72 M
|
$85.25 M
|
$58.53 M
|
$50.13 M
|
$28.15 M
|
| General & Administrative Expenses |
$37.78 M
|
$50.85 M
|
$44.46 M
|
$33.85 M
|
$22.58 M
|
$12.17 M
|
$9.18 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$37.78 M
|
$50.85 M
|
$44.46 M
|
$33.85 M
|
$22.58 M
|
$12.17 M
|
$9.18 M
|
| Other Expenses |
$63.20 M
|
$0.00
|
$0.00
|
$0.00
|
-$3.43 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$162.28 M
|
$144.47 M
|
$141.18 M
|
$119.10 M
|
$77.68 M
|
$62.30 M
|
$37.33 M
|
| Cost And Expenses |
$162.28 M
|
$144.47 M
|
$141.18 M
|
$119.10 M
|
$81.11 M
|
$62.30 M
|
$37.33 M
|
| Interest Income |
$10.72 M
|
$11.95 M
|
$4.54 M
|
$187.00 K
|
$591.00 K
|
$0.00
|
$1.49 M
|
| Interest Expense |
$0.00
|
$0.00
|
$4.54 M
|
$50.00 K
|
$591.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$4.93 M
|
$5.26 M
|
$5.13 M
|
$4.53 M
|
$3.43 M
|
$1.86 M
|
$347.00 K
|
| EBITDA |
-$74.26 M |
-$133.30 M |
-$136.05 M |
-$114.57 M |
-$77.09 M |
-$60.44 M |
-$36.95 M |
| EBITDA Ratio |
-3.73
|
-22.58
|
0
|
0
|
0
|
0
|
-1026.31
|
| Operating Income Ratio |
-7.16
|
-23.47
|
0
|
0
|
0
|
0
|
-1035.94
|
| Total Other Income/Expenses Net |
$10.72 M
|
$11.95 M
|
$4.54 M
|
-$50.00 K
|
$591.00 K
|
$985.00 K
|
$1.49 M
|
| Income Before Tax |
-$131.67 M
|
-$126.61 M
|
-$136.64 M
|
-$119.15 M
|
-$80.52 M
|
-$61.32 M
|
-$35.80 M
|
| Income Before Tax Ratio |
-6.62
|
-21.45
|
0
|
0
|
0
|
0
|
-994.53
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$131.67 M
|
-$126.61 M
|
-$136.64 M
|
-$119.15 M
|
-$80.52 M
|
-$60.33 M
|
-$35.80 M
|
| Net Income Ratio |
-6.62
|
-21.45
|
0
|
0
|
0
|
0
|
-994.53
|
| EPS |
-19.76 |
-19.63 |
-23.51 |
-21.17 |
-29.54 |
-13.1 |
-18.2 |
| EPS Diluted |
-19.76 |
-19.63 |
-23.51 |
-21.17 |
-29.54 |
-13.1 |
-18.2 |
| Weighted Average Shares Out |
$6.66 M
|
$6.45 M
|
$5.81 M
|
$5.63 M
|
$2.73 M
|
$4.62 M
|
$1.97 M
|
| Weighted Average Shares Out Diluted |
$6.66 M
|
$6.45 M
|
$5.81 M
|
$5.63 M
|
$2.73 M
|
$4.62 M
|
$1.97 M
|
| Link |
|
|
|
|
|
|
|
